J&J lifts 2016 estimates as dollar weakens
Johnson & Johnson (JNJ.N) beat quarterly earnings forecasts and slightly boosted its 2016 outlook, citing strong prescription drug revenue and a weakening dollar that will help improve sales in overseas markets. In a possibly encouraging signal for other drugmakers that will be reporting results in coming weeks, J&J said the ... Read More »